The Healthcare Sales & Marketing Network(R): Sales & Marketing News, Information and Networking for Medical Devices, Pharmaceuticals and Biotechnology.
Sales & Marketing News, Information and Networking for Medical Devices, Pharmaceuticals and Biotechnology.
Main Page: Medical News Roundups and more Medical Device and Biotech/Pharmaceutical News Medical Meetings and Conventions Calendar Message Boards for Medical Sales and Marketing Professionals, Distributors and Independent Sales Reps in Devices, Biopharmaceuticals and Diagnostics Medical Device Companies, Biotech/Pharmaceutical Companies, Distributors and Independent Sales Reps Members sections: News Roundups, News Archives, SuperSearch, Directory of Medical Sales and Marketing Professionals
Healthcare Sales & Marketing Network celebrates twelve years serving the medical device, biopharmaceutical and diagnostics community!
Company Profiles
 
  INDUSTRY NEWSFEED 
  PEOPLE in the NEWS 
 RSS/XML NewsFeed and JobsFeed from The Network directly to your NewsReaderPublic Feeds 
  MEETINGS CALENDAR 
  POSITIONS AVAILABLE 
  —New Jobs: AUG 20 
  RECRUITERS DIRECTORY 
  DISTRIBUTORS - USA  
  DISTRIBUTORS - INTL  
  DISTRIBUTORS - ALL  
  MESSAGE BOARDS  
  HOSPITALS - USA   
  MARKET RESEARCH  
  COMPANY PROFILES  
  MEDICAL DEVICES 
  BIOPHARMACEUTICALS 
  PROFESSIONAL Orgs 
  GOVT / REGULATORY 
  PRODUCTS & SERVICES  
  VENTURE CAPITAL  
 
Market Research Marketplace: reports and industry analysis from leading market research firms
 
   MEMBERS: 
  MY NEWSPAGE 
  SuperSEARCH   
  MOBILE NEWS   New!  
 RSS/XML NewsFeeds by category from The Network directly to your NewsReaderNewsFeeds 
  NewsTRACKER  
  NewsARCHIVE  
  EDIT ONLINE BIO 
  MEMBER DIRECTORY 
  MEMBER HOTLINE 
  MEMBER SERVICES 
 
 
 
  ABOUT The Network 
  MEMBERSHIP INFO 
  JOIN The Network 
  SUBMIT NEWS RELEASE 
  HELP / FAQs 
  ADVERTISING INFO 
  CONTACT US 
  HOME 
 


Your life 24/7: Delphi Vital Information Manager
  		 
Company Profiles: Medical Devices, Biotechnology and Pharmaceuticals
       
Abbott Laboratories: PharmaVitae Profile

       
Acambis PLC: Premium Company Profile

       
Achillion Pharmaceuticals: Company Profile

       
Acorda Therapeutics: Premium Company Profile

       
Actelion Ltd: PharmaVitae Profile

       
Akzo Nobel/Organon: PharmaVitae Profile

       
Alcon Inc.: PharmaVitae Profile

       
Alexion Pharmaceuticals: Company Profile

       
Alexza Pharmaceuticals: Company Profile

       
Allergan: PharmaVitae Profile

       
Allos Therapeutics: Premium Company Profile

       
Almirall: PharmaVitae Profile

       
Alpharma: Premium Company Profile

       
Altana: PharmaVitae Profile

       
Altus Pharmaceuticals: Company Profile

       
Amgen Inc.: PharmaVitae Profile

       
Amylin Pharmaceuticals: Premium Company Profile

       
Anesiva Inc: Premium Company Profile

       
Antares Pharma: Premium Company Profile

       
Antisoma plc: Premium Company Profile

       
ArQule Inc: Premium Company Profile

       
Aspreva Pharmaceuticals Corporation: Premium Company Profile

       
Astellas: PharmaVitae Profile

       
AstraZeneca plc: PharmaVitae Profile

       
Auxilium Pharmaceuticals: Premium Company Profile

       
Avigen Inc: Premium Company Profile

       
Barr Pharmaceuticals Inc.: PharmaVitae Profile

       
Barrier Therapeutics: Premium Company Profile

       
Bayer Schering Pharma AG: PharmaVitae Profile

       
Beckman Coulter Inc: Premium Company Profile

       
Becton, Dickinson and Co: Premium Company Profile

       
Biogen Idec: PharmaVitae Profiles

       
BioMarin Pharmaceutical: Premium Company Profile

       
BIOMS Medical Corp: Premium Company Profile

       
Boehringer Ingelheim GmbH: PharmaVitae Profile

       
Boston Scientific Corporation: Premium Company Profile

       
Bracco: Company Profile

       
Bristol-Myers Squibb Co.: PharmaVitae Profile

       
C.R. Bard Inc: Premium Company Profile

       
Cardinal Health: Company Profile

       
Cardiome Pharma Corp: Premium Company Profile

       
Carl Zeiss Meditec AG: Premium Company Profile

       
Celgene Corporation: PharmaVitae Profile

       
Cephalon: PharmaVitae Profile

       
Chiron: PharmaVitae Profile

       
Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile

       
CollaGenex: Premium Company Profile

       
Cougar Biotechnology Inc: Premium Company Profile

       
CSL Limited: Premium Company Profile

       
Cubist Pharmaceuticals: Premium Company Profile

       
CuraGen: Premium Company Profile

       
CV Therapeutics: Premium Company Profile

       
Cypress Bioscience Inc: Premium Company Profile

       
Cytogen: Premium Company Profile

       
Cytokinetics Inc: Premium Company Profile

       
Cytori Therapeutics Inc: Premium Company Profile

       
Daiichi Sankyo: PharmaVitae Profile

       
Dainippon Sumitomo Pharma: PharmaVitae Profile 2005

       
Danaher Corporation: Premium Company Profile

       
Depomed: Premium Company Profile

       
Discovery Laboratories: Premium Company Profile

       
DURECT Corporation: Premium Company Profile

       
Dyax: Premium Company Profile

       
Dynavax Technologies Corp: Premium Company Profile

       
Eisai: PharmaVitae Profile

       
Elan Corporation: Premium Company Profile

       
Eli Lilly & Co.: PharmaVitae Profile

       
Encysive Pharmaceuticals: Premium Company Profile

       
Endo Pharmaceuticals: Premium Company Profile

       
EPIX Pharmaceuticals Inc: Premium Company Profile

       
F. Hoffmann-La Roche Ltd.: PharmaVitae Profile

       
Forest Laboratories: PharmaVitae Profile

       
Gedeon Richter: Premium Company Profile

       
Genentech Inc.: PharmaVitae Profile

       
Genmab: Premium Company Profile

       
Genzyme Corporation: PharmaVitae Profile

       
Gilead Sciences: PharmaVitae Profile

       
GlaxoSmithKline plc: PharmaVitae Profile

       
GPC Biotech AG: Premium Company Profile

       
GTC Biotherapeutics Inc: Premium Company Profile

       
GTx, Inc.: Premium Company Profile

       
Guerbet: Company Profile

       
H. Lundbeck: PharmaVitae Profile

       
Human Genome Sciences: Premium Company Profile

       
Idenix Pharmaceuticals: Premium Company Profile

       
Illumina Inc: Premium Company Profile

       
ImClone Systems: Premium Company Profile

       
ImmunoGen: Premium Company Profile

       
Incyte Corporation: Premium Company Profile

       
Introgen Therapeutics Inc: Premium Company Profile

       
Invitrogen Corporation: Premium Company Profile

       
Ipsen: PharmaVitae Profile

       
Javelin Pharmaceuticals Inc: Premium Company Profile

       
Johnson & Johnson: PharmaVitae Profile

       
Keryx Biopharmaceuticals: Premium Company Profile

       
King Pharmaceuticals: PharmaVitae Profile

       
KV Pharmaceutical Company: Premium Company Profile

       
La Jolla Pharmaceutical Co: Premium Company Profile

       
Lev Pharmaceuticals Inc: Premium Company Profile

       
Lexicon Pharmaceuticals Inc: Premium Company Profile

       
LifeCell Corporation: Premium Company Profile

       
Lundbeck: PharmaVitae Profile

       
MannKind Corporation: Premium Company Profile

       
Martek Biosciences Corp: Premium Company Profile

       
Maxygen: Premium Company Profile

       
Medarex: Premium Company Profile

       
MedImmune: PharmaVitae Profile

       
Medtronic Inc: Premium Company Profile

       
Menarini: PharmaVitae Profile

       
Merck & Co: PharmaVitae Profile

       
Merck Serono Biopharmaceuticals: PharmaVitae Profile

       
MGI Pharm: Premium Company Profile

       
Micromet Inc: Premium Company Profile

       
Millennium: PharmaVitae Profile

       
Mitsubishi: PharmaVitae Profile 2005

       
MorphoSys AG: Premium Company Profile

       
Mylan: PharmaVitae Profile

       
Nastech Pharmaceutical: Premium Company Profile

       
Neurocrine Biosciences: Premium Company Profile

       
Neurogen Corporation: Premium Company Profile

       
Novacea Inc: Premium Company Profile

       
Novartis AG: PharmaVitae Profile

       
Novavax: Premium Company Profile

       
Novo Nordisk A/S: PharmaVitae Profile

       
Nuvelo Inc: Premium Company Profile

       
Nycomed A/S: PharmaVitae Profile

       
Optimer Pharmaceuticals Inc: Premium Company Profile

       
Organon: PharmaVitae Profile

       
OSI Pharmaceuticals: Premium Company Profile

       
Pain Therapeutics: Premium Company Profile

       
Panacos Pharmaceuticals Inc: Premium Company Profile

       
Pfizer Inc.: PharmaVitae Profile

       
PharmaVitae Generics - Teva

       
PharmaVitae: Company Comparator Tool

       
Pharmion Corporation: Premium Company Profile

       
Philips Medical Systems: Company Profile

       
Pierre Fabre: PharmaVitae Profile

       
Poniard Pharmaceuticals Inc: Premium Company Profile

       
Progenics Pharmaceuticals: Premium Company Profile

       
QLT Inc: Premium Company Profile

       
Recordati: PharmaVitae Profile

       
Roche: PharmaVitae Profile

       
Sandoz: PharmaVitae Profile

       
sanofi-aventis: PharmaVitae Profile

       
Santarus: Premium Company Profile

       
Savient Pharmaceuticals: Premium Company Profile

       
Schering AG: PharmaVitae Profile

       
Schering-Plough Corporation: PharmaVitae Profile

       
Sepracor: PharmaVitae Profile

       
Serono: PharmaVitae Profile

       
Servier: PharmaVitae Profile

       
Shionogi: PharmaVitae Profile

       
Shire plc: PharmaVitae Profile

       
Smith & Nephew plc: Premium Company Profile

       
Solvay: PharmaVitae Profile

       
Sonus Pharmaceuticals Inc: Premium Company Profile

       
Spectrum Pharmaceuticals Inc: Premium Company Profile

       
St. Jude Medical Inc: Premium Company Profile

       
Stryker Corporation: Premium Company Profile

       
Sunesis Pharmaceuticals: Premium Company Profile

       
Takeda: PharmaVitae Profile

       
Tanox: Premium Company Profile

       
Teva Pharmaceutical Industries Ltd: PharmaVitae Profile

       
The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles

       
Theratechnologies Inc: Premium Company Profile

       
TorreyPines Therapeutics Inc: Premium Company Profile

       
Toshiba: Company Profile

       
Transition Therapeutics Inc: Premium Company Profile

       
UCB S.A.: PharmaVitae Profile

       
UCB Schwarz: PharmaVitae Profile

       
United Therapeutics: Premium Company Profile

       
Varian Medical Systems Inc: Premium Company Profile

       
Vertex Pharmaceuticals: Premium Company Profile

       
ViroPharma: Premium Company Profile

       
Warner Chilcott Ltd: Premium Company Profile

       
Watson Pharmaceuticals Inc.: PharmaVitae Profile

       
Wyeth: PharmaVitae Profile

       
Zimmer Holdings Inc: Premium Company Profile

       

 

  
     
Top Selling Reports...

Genmab: Premium Company Profile

The Latin American Cardiovascular Market Outlook to 2010

In Pursuit of the Paperless Clinical Trial: A look at EDC and CTMS (Strategy Focus)

TorreyPines Therapeutics Inc: Premium Company Profile

Allos Therapeutics: Premium Company Profile

Regulator Perceptions in Cancer - Evolving opinions about the oncology drug approval process

Commercial Insight: Multiple Sclerosis Continued growth makes the MS market a highly attractive investment

Pipeline Insight: Cancer Overview Emerging Therapeutic and Commercial Opportunities

Warner Chilcott Ltd: Premium Company Profile

Commercial Insight: Antidiabetics Patent expiries and cost containment initiatives balanced by pipeline products

Commercial Insight: Transplantation

The Top 10 Generic Pharmaceutical Companies: Positioning, performance and SWOT analyses

Pipeline Insight: Non-Small Cell Lung Cancer Avastin to lead the market

Cougar Biotechnology Inc: Premium Company Profile

Stakeholder Opinions: Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of market prospects for biologics expose an opportunity for cell and gene therapies

Biosimilars Series: Strategic issues - Potential remains uncertain

ImClone Systems: Premium Company Profile

Dainippon Sumitomo Pharma: PharmaVitae Profile 2005

Divestment Strategies: Pharma is divesting in order to grow

Pipeline Insight: Acute Stroke: Commercial risk offsets high unmet need

Pharmaceutical Outsourcing Part 2: An Introduction to Drug Discovery Strategies – new opportunities lie in a fully integrated global outsourcing strategy

Commercial & Pipeline Insight: Hospital Antibacterials A market beyond MRSA

Zimmer Holdings Inc: Premium Company Profile

Stakeholder Insight: Supportive Care in Cancer Treatment - Some first-generation products proving difficult to dislodge

Cardinal Health: Company Profile

Stakeholder Opinions: Hepatocellular Carcinoma - Opportune indication for novel therapies

Pipeline Insight: Substance Dependence - Part II: Alcohol

Management of Urinary Incontinence and Overactive Bladder - A Global Overview

Stakeholder Opinions: Endometriosis - Scientific clarity will unlock market potential

Lexicon Pharmaceuticals Inc: Premium Company Profile

The Eastern European Cardiovascular Market Outlook to 2010

Endo Pharmaceuticals: Premium Company Profile

Orthopedics: Global Industry Guide

Millennium: PharmaVitae Profile

Stakeholder Opinions: Osteoarthritis - Preconceptions Damage Awareness and Treatments

Medtronic Inc: Premium Company Profile

The Asthma, COPD & Allergic Rhinitis Market Outlook to 2011

Stakeholder Opinions: Vaccine adjuvants - uncertainties rule

Pipeline Insight: Antihypertensives - Weak pipeline leaves innovation to Novartis

Anti-Counterfeiting Strategies - Combating Fake Pharmaceuticals

Pipeline Insight: Molecular Targeted Cancer Therapies Can anything else revolutionize the market?

Contract Manufacturing Strategies: Market developments, technology transfer and key success factors

Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players

Merck Serono Biopharmaceuticals: PharmaVitae Profile

Financial Markets Research: Bausch & Lomb's Contact Lens Solution Withdrawal - ReNu MultiPlus likely to struggle in attempt to regain market share

Autoimmune Market Outlook to 2012

Pipeline Insight: Depression - Novel drugs to grow third-line market

Pipeline Insight: Orphan Diseases in CNS - Part II: Amyotrophic Lateral Sclerosis

Pipeline Insight: Antiarrhythmics - RSD1235 in a class of its own

CSL Limited: Premium Company Profile

Eli Lilly & Co.: PharmaVitae Profile

Lundbeck: PharmaVitae Profile

Monoclonal Antibodies Report Part I

eHealthInsight Series: Online Pharmacies - Implications for the Pharmaceutical Industry

Mylan: PharmaVitae Profile

Commercial and Pipeline Insight: ADHD - Immature adult market continues to offer greatest commercial potential

GPC Biotech AG: Premium Company Profile

Stakeholder Opinions: Sepsis - Under reaction to an overreaction

UCB Schwarz: PharmaVitae Profile

Pipeline Insight: Migraine - Innovation essential as weak late-stage pipeline fails to hold off the impact of triptan patent expiries

Indication Expansion: Opportunities for successful lifecycle management

Commercial Insight: Rheumatoid arthritis - Anti-TNFs defend first-line biologic position despite competition

Celgene Corporation: PharmaVitae Profile

Commercial Insight: Top 20 Therapy Cancer Brands - Key brands set to consolidate advantage as competition intensifies

Mitsubishi: PharmaVitae Profile 2005

La Jolla Pharmaceutical Co: Premium Company Profile

Cephalon: PharmaVitae Profile

Beckman Coulter Inc: Premium Company Profile

Stakeholder Opinions: Biologics in Infectious Diseases Well defined target populations are key to commercial success

Stakeholder Opinions: Restless Legs Syndrome - Novel drugs to prosper as lifecycle management strategies fail

Stakeholder Opinions: Gynecological Cancers - Niche opportunities in advanced disease

Organon: PharmaVitae Profile

Pipeline and Commercial Insight: Alzheimer's Disease - Scenario forecasts reveal vast market potential

Stakeholder Insight: Spondyloarthropathies - Disease perception limits market potential

Menarini: PharmaVitae Profile

Parallel Trade in Europe and the US: The challenges facing pharma

Sales Force Effectiveness

Micromet Inc: Premium Company Profile

The Gastrointestinal Market Outlook to 2010

Daiichi Sankyo: PharmaVitae Profile

Commercial Insight: Antihormonal Therapy Cancer Brands - Careful lifecycle management needed to preserve brand dominance

Commercial Insight: Cytotoxic Therapy Cancer Brands - Looming patent expiries limit market growth

Commercial Insight: Depression - Atypical lifecycle management strategy rejuvenates depression market

Alcon Inc.: PharmaVitae Profile

Novartis AG: PharmaVitae Profile

Bracco: Company Profile

Avigen Inc: Premium Company Profile

Stakeholder Insight: Rheumatoid Arthritis - Biologics battle up the treatment algorithm

Commercial Insight: Inflammatory Bowel Disease - Convenience and compliance drive market success

Innovations in Diagnostics: Next generation molecular and point-of-care diagnostics driving personalized healthcare

Stakeholder Insight: Non-Small Cell Lung Cancer - The need for greater product differentiation in an increasingly crowded market

Personalizing Disease Management Through Technology Solutions: Part II - Vendor Landscape

Forecast Insight: Epilepsy - Future market upgrade following new drug launches

Forecast Insight: Asthma/COPD - Little long-term future for long-acting single-agent inhalers?

Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries

Actelion Ltd: PharmaVitae Profile

Commercial Insight: Antidyslipidemics - The competitive cost-conscious antidyslipidemics market presents challenges

Recordati: PharmaVitae Profile

Stakeholder Opinion: Atopic Dermatitis - A high level of unmet need creates market opportunities

ArQule Inc: Premium Company Profile

 

 

 HOME    •    NEWSFEED    •     MEETINGS & CONVENTIONS    •    FORUM    •    LINKS    •    TOP   
Copyright © 1998-2010 The Healthcare Sales & Marketing Network. All rights reserved.
The Healthcare Sales & Marketing Network is a registered trademark of Healthcare Sales & Marketing Network, LLC.
Powered by Redhat Enterprise Linux 4ES